000 01373 a2200361 4500
005 20250515050444.0
264 0 _c20070228
008 200702s 0 0 ger d
022 _a0040-5930
024 7 _a10.1024/0040-5930.63.12.777
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHaefeli, W E
245 0 0 _a[Individualising the evidence--single case randomized trial].
_h[electronic resource]
260 _bTherapeutische Umschau. Revue therapeutique
_cDec 2006
300 _a777-81 p.
_bdigital
500 _aPublication Type: Case Reports; English Abstract; Journal Article; Randomized Controlled Trial
650 0 4 _aAdrenergic alpha-Antagonists
_xadverse effects
650 0 4 _aAntihypertensive Agents
_xtherapeutic use
650 0 4 _aBlood Pressure Monitoring, Ambulatory
650 0 4 _aDouble-Blind Method
650 0 4 _aErectile Dysfunction
_xdrug therapy
650 0 4 _aEvidence-Based Medicine
650 0 4 _aHumans
650 0 4 _aHypertension
_xchemically induced
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNifedipine
_xtherapeutic use
650 0 4 _aPain Measurement
650 0 4 _aRisk Factors
650 0 4 _aYohimbine
_xadverse effects
773 0 _tTherapeutische Umschau. Revue therapeutique
_gvol. 63
_gno. 12
_gp. 777-81
856 4 0 _uhttps://doi.org/10.1024/0040-5930.63.12.777
_zAvailable from publisher's website
999 _c16703812
_d16703812